XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$56.44
+0.44 (+0.79%)
Performance
1D
—
1W
—
1M
—
3M
+33.02%
6M
+46.94%
1Y
+61.17%
YTD
+26.86%
Open$56.13
Previous Close$56.00
Day High$57.47
Day Low$55.73
52W High$63.95
52W Low$28.19
Volume—
Avg Volume1.02M
Market Cap5.51B
P/E Ratio—
EPS$-4.36
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.54
Above
SMA 200
$37.78
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-64.6% upside
Current
$56.44
$56.44
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.23M | 9.97M | 1.14B |
| Net Income | -426,077,835 | -413,891,043 | -213,860,892 |
| Profit Margin | -4,612.1% | -4,381.5% | -18.8% |
| EBITDA | -456,399,004 | -467,975,233 | -248,558,556 |
| Free Cash Flow | — | — | -268,893,932 |
| Rev Growth | -7.4% | -7.4% | +15.1% |
| Debt/Equity | — | — | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |